-
121
-
122
Effectiveness of PK-Guided Personalized Recombinant FVIII Treatment in Patients with Hemophilia A: Clinical Case Experiences Based on an Observational Study
Published 2025-01-01“…Yoko Mizoguchi,1 Moeko Hino,2 Hitoshi Ueda,3 Yasuo Miyaguchi,3 Masao Kobayashi1,4 1Department of Pediatrics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan; 2Department of Pediatrics, Chiba University Hospital, Chiba, Japan; 3Japan Medical Office, Takeda Pharmaceutical Company Limited, Tokyo, Japan; 4Japanese Red Cross, Chugoku-Shikoku Block Blood Center, Hiroshima, JapanCorrespondence: Yasuo Miyaguchi, Japan Medical Office, Takeda Pharmaceutical Company Limited, 2 Chome-1-1 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023, Japan, Tel +81 70-4921-7966, Email yasuo.miyaguchi1@takeda.comPurpose: Prophylaxis with recombinant factor VIII (rFVIII) products is the gold-standard treatment for hemophilia A. …”
Get full text
Article -
123
-
124
Occupants’ Thermal Adaptive Behavior Pattern in Indonesian Residential Buildings
Published 2024-12-01Get full text
Article -
125
-
126
De Novo Renal Cell Carcinoma in a Kidney Allograft 20 Years after Transplant
Published 2015-01-01Get full text
Article -
127
-
128
-
129
Comparative effects of methamphetamine, cannabis, and polysubstance use on oral health
Published 2025-01-01“…Sociodemographic data, substance use history, and oral health behaviors were collected using a researcher-developed questionnaire and the Turkish version of the Hiroshima University Dental Behavior Inventory (HU-DBI). …”
Get full text
Article -
130
-
131
A comprehensive analysis of the acromial morphology and etiological factors of partial rotator cuff tears
Published 2025-01-01Get full text
Article -
132
-
133
-
134
-
135
-
136
Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study
Published 2025-02-01Get full text
Article -
137
-
138
-
139
-
140